Cargando…

Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System

The purpose of this quality improvement project was to evaluate the impact of clinical pharmacy specialist (CPS) involvement in the post-discharge period on 30-day readmission rates within a Veterans Affairs Healthcare System. Patients eligible for inclusion were discharged from a Veterans Affairs (...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Morgan, Cardoza, Amber, Gordon, Autumn, Howard, Molly, Neighbors, Lynsey, Ragan, Addison
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151698/
https://www.ncbi.nlm.nih.gov/pubmed/32235777
http://dx.doi.org/10.3390/pharmacy8010047
_version_ 1783521309752295424
author Fisher, Morgan
Cardoza, Amber
Gordon, Autumn
Howard, Molly
Neighbors, Lynsey
Ragan, Addison
author_facet Fisher, Morgan
Cardoza, Amber
Gordon, Autumn
Howard, Molly
Neighbors, Lynsey
Ragan, Addison
author_sort Fisher, Morgan
collection PubMed
description The purpose of this quality improvement project was to evaluate the impact of clinical pharmacy specialist (CPS) involvement in the post-discharge period on 30-day readmission rates within a Veterans Affairs Healthcare System. Patients eligible for inclusion were discharged from a Veterans Affairs (VA) acute care facility with a principle or secondary diagnosis of heart failure (HF), chronic obstructive pulmonary disease (COPD), or both HF and COPD from 15 October 2018 through 14 January 2019. CPSs functioning as a mid-level provider with a scope of practice conducted telephone and in-clinic medication management appointments within 7 and 21 days post-discharge for qualifying patients discharged with a principle or secondary diagnosis of HF or COPD. CPS appointments focused on medication reconciliation, ensuring continuity of care, disease state counseling, and medication management. By enhancing the role of the CPS in the post-discharge period, there was an observed decrease in 30-day COPD index (p = 0.35), HF index (p = 0.23), and all-cause (p = 0.62) readmission rates from pre- to post-intervention. The results of this intervention show that CPS intervention in the post-discharge period may reduce index and all-cause readmission rates for patients discharged with a principle or secondary discharge diagnosis of COPD or HF.
format Online
Article
Text
id pubmed-7151698
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71516982020-04-20 Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System Fisher, Morgan Cardoza, Amber Gordon, Autumn Howard, Molly Neighbors, Lynsey Ragan, Addison Pharmacy (Basel) Article The purpose of this quality improvement project was to evaluate the impact of clinical pharmacy specialist (CPS) involvement in the post-discharge period on 30-day readmission rates within a Veterans Affairs Healthcare System. Patients eligible for inclusion were discharged from a Veterans Affairs (VA) acute care facility with a principle or secondary diagnosis of heart failure (HF), chronic obstructive pulmonary disease (COPD), or both HF and COPD from 15 October 2018 through 14 January 2019. CPSs functioning as a mid-level provider with a scope of practice conducted telephone and in-clinic medication management appointments within 7 and 21 days post-discharge for qualifying patients discharged with a principle or secondary diagnosis of HF or COPD. CPS appointments focused on medication reconciliation, ensuring continuity of care, disease state counseling, and medication management. By enhancing the role of the CPS in the post-discharge period, there was an observed decrease in 30-day COPD index (p = 0.35), HF index (p = 0.23), and all-cause (p = 0.62) readmission rates from pre- to post-intervention. The results of this intervention show that CPS intervention in the post-discharge period may reduce index and all-cause readmission rates for patients discharged with a principle or secondary discharge diagnosis of COPD or HF. MDPI 2020-03-22 /pmc/articles/PMC7151698/ /pubmed/32235777 http://dx.doi.org/10.3390/pharmacy8010047 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Fisher, Morgan
Cardoza, Amber
Gordon, Autumn
Howard, Molly
Neighbors, Lynsey
Ragan, Addison
Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System
title Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System
title_full Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System
title_fullStr Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System
title_full_unstemmed Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System
title_short Enhancing Clinical Pharmacy Specialist Involvement in Transitions of Care Focusing on Ambulatory Care Sensitive Conditions within a Veterans Affairs Healthcare System
title_sort enhancing clinical pharmacy specialist involvement in transitions of care focusing on ambulatory care sensitive conditions within a veterans affairs healthcare system
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151698/
https://www.ncbi.nlm.nih.gov/pubmed/32235777
http://dx.doi.org/10.3390/pharmacy8010047
work_keys_str_mv AT fishermorgan enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem
AT cardozaamber enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem
AT gordonautumn enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem
AT howardmolly enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem
AT neighborslynsey enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem
AT raganaddison enhancingclinicalpharmacyspecialistinvolvementintransitionsofcarefocusingonambulatorycaresensitiveconditionswithinaveteransaffairshealthcaresystem